Holen Sie sich die Stockscreener-App
2.60
4.42%
0.11
Handel nachbörslich:
2.57
-0.03
-1.15%
Schlusskurs vom Vortag:
$2.49
Offen:
$2.53
24-Stunden-Volumen:
583.43K
Relative Volume:
0.27
Marktkapitalisierung:
$236.33M
Einnahmen:
$70.39M
Nettoeinkommen (Verlust:
$-43.97M
KGV:
-5.0183
EPS:
-0.5181
Netto-Cashflow:
$-23.85M
1W Leistung:
+5.69%
1M Leistung:
-0.76%
6M Leistung:
+49.43%
1J Leistung:
+8.33%
1-Tages-Spanne:
$2.5016
$2.60
1-Wochen-Bereich:
$2.40
$2.60
52-Wochen-Spanne:
$0.9583
$3.87
Codexis Inc Stock (CDXS) Company Profile
Firmenname
Codexis Inc
Sektor
Branche
Telefon
650-421-8100
Adresse
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Compare CDXS vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDXS
Codexis Inc
|
2.60 | 226.33M | 70.39M | -43.97M | -23.85M | -0.5181 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Codexis Inc Stock (CDXS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-19 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-05-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-02-29 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2023-11-07 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-08-07 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-05-09 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2022-03-31 | Fortgesetzt | Piper Sandler | Overweight |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2021-04-12 | Eingeleitet | Piper Sandler | Overweight |
| 2021-03-01 | Eingeleitet | Stifel | Buy |
| 2021-02-26 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-10 | Eingeleitet | The Benchmark Company | Buy |
| 2019-01-17 | Hochstufung | First Analysis Sec | Neutral → Outperform |
| 2018-05-16 | Eingeleitet | Stephens | Overweight |
| 2017-10-13 | Bestätigt | H.C. Wainwright | Buy |
| 2017-05-31 | Eingeleitet | Jefferies | Buy |
| 2017-01-26 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-01-04 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2016-01-06 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Codexis Inc Aktie (CDXS) Neueste Nachrichten
CDXS Stock Price, Quote & Chart | CODEXIS INC (NASDAQ:CDXS) - ChartMill
Codexis highlights stereochemistry advances for scalable RNA manufacturing at TIDES USA - Yahoo Finance
Q1 2026 Codexis Inc Earnings Call Transcript - GuruFocus
Q3 2025 Codexis Inc Earnings Call Transcript - GuruFocus
TradingKey - TradingKey
US$6.58: That's What Analysts Think Codexis, Inc. (NASDAQ:CDXS) Is Worth After Its Latest Results - simplywall.st
Number of shareholders of Codexis, Inc. – NASDAQ:CDXS - TradingView
Earnings Release: Here's Why Analysts Cut Their Codexis, Inc. (NASDAQ:CDXS) Price Target To US$6.58 - Yahoo Finance
MSN Money - MSN
Codexis, Inc. (NASDAQ:CDXS) Q1 2026 Earnings Call Transcript - Insider Monkey
Craig-Hallum Maintains Codexis(CDXS.US) With Buy Rating, Announces Target Price $9 - Moomoo
Codexis (NASDAQ:CDXS) Issues Quarterly Earnings Results - MarketBeat
Codexis (CDXS) Q1 2026 Earnings Transcript - AOL.com
Codexis (CDXS) Reports Q1 2026 Earnings and Highlights Growth Pr - GuruFocus
Codexis reiterates $72M-$76M 2026 revenue outlook while targeting 0.5 kilogram ECO Synthesis scale by year-end - MSN
Codexis (CDXS) Reports Strong Q1 Revenue and Upcoming Data Prese - GuruFocus
Codexis, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Codexis (CDXS) Confident in Financial Stability Through 2027 - GuruFocus
Codexis: Q1 Earnings Snapshot - theheraldreview.com
Earnings call transcript: Codexis beats Q1 2026 EPS forecast, stock rises - Investing.com
Earnings call transcript: Codexis beats Q1 2026 EPS forecast, stock rises By Investing.com - Investing.com South Africa
Codexis (NASDAQ:CDXS) Q1 Results Beat Estimates as Company Reaffirms Full-Year Guidance - ChartMill
Codexis (CDXS) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
CDXS: Strong Q1 growth and expanding ECO Synthesis platform position the company for robust 2026 performance - TradingView
CDXS: Q1 2026 revenue doubled and gross margin rose to 71%, with ECO Synthesis gaining industry traction - TradingView
Codexis Q1 Earnings Call Highlights - MarketBeat
Codexis says it has cash through 2027 as siRNA plans advance - Stock Titan
Codexis Reports First Quarter 2026 Financial Results - The Manila Times
Codexis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Revenue surges as Codexis (CDXS) narrows quarterly loss and manages debt load - Stock Titan
Codexis (NASDAQ: CDXS) Q1 2026 revenue hits $15.2M as net loss shrinks - Stock Titan
Codexis, Inc. Reiterates Earnings Guidance for the Full Year 2026 - marketscreener.com
Opaleye (NASDAQ: CDXS) holds 7.47% of Codexis, 6.785M shares - Stock Titan
Codexis (NASDAQ:CDXS) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
Codexis to Report First Quarter 2026 Financial Results on May 7 - 富途牛牛
Earnings Preview: Codexis to Report Financial Results Post-market on May 07 - Moomoo
Codexis (CDXS) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release - Yahoo Finance
Codexis (CDXS) Projected to Post Earnings on Thursday - MarketBeat
Codexis rises after Q4 beat, strong outlook - MSN
Codexis to share RNA manufacturing advances at TIDES USA - GlobeNewswire
[ARS] CODEXIS, INC. SEC Filing - Stock Titan
Codexis (NASDAQ: CDXS) details 2026 virtual meeting, board elections and audit vote - Stock Titan
Codexis (NASDAQ:CDXS) Rating Increased to Buy at Wall Street Zen - MarketBeat
Codexis (NASDAQ:CDXS) Share Price Crosses Above 200-Day Moving AverageWhat's Next? - MarketBeat
Finanzdaten der Codexis Inc-Aktie (CDXS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.98%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):